Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment - The role of fatigue

NeuroImage: Clinical

Volumn 7, Issue , 2015, Pages 547-554

  Menning, Sanne ^a,b   De Ruiter, Michiel B ^a,b   Veltman, Dick J ^c   Koppelmans, V ^d   Kirschbaum, Clemens ^e   Boogerd, Willem ^a   Reneman, Liesbeth ^b   Schagen, Sanne B ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF MICHIGAN   (United States)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Breast cancer; Cognition; Fatigue; Magnetic resonance imaging

Indexed keywords

HYDROCORTISONE;

ADULT; AGED; ARTICLE; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN SIZE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; COGNITION; CONTROLLED STUDY; FATIGUE; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SELF REPORT; SOCIAL PSYCHOLOGY; STRESS; TASK PERFORMANCE; WHITE MATTER; ADJUVANT CHEMOTHERAPY; BRAIN; BREAST NEOPLASMS; COGNITION DISORDERS; MENTAL STRESS; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE;

BRAIN; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; FATIGUE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES;

EID: 84939140378     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2015.02.005     Document Type: Article

References (40)

1. Ahles T.A., Saykin A.J., McDonald B.C., Furstenberg C.T., Cole B.F., Hanscom B.S., Mulrooney T.J., Schwartz G.N., and Kaufman P.A. Cognitive function in breast cancer patients prior to adjuvant treatment Breast Cancer Res. Treat. 110 1 2008 143 152 10.1007/s10549-007-9686-5 17674194
2. Berman M.G., Askren M.K., Jung M., Therrien B., Peltier S., Noll D.C., Zhang M., Ossher L., Hayes D.F., Reuter-Lorenz P.A., and Cimprich B. Pretreatment worry and neurocognitive responses in women with breast cancer Health Psychol. Off. J. Div. Health Psychol. Am. Psychol. Assoc. 33 3 2014 222 231 10.1037/a0033425 23914817
3. Bower J.E., Ganz P.A., Irwin M.R., Kwan L., Breen E.C., and Cole S.W. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? Journal of Clinical Oncology 29 26 2011 3517 3522 10.1200/JCO.2011.36.1154
4. Cheung Y.T., Lim S.R., Ho H.K., and Chan A. Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research PLOS One 8 12 2013 e81234 10.1371/journal.pone.0081234 24339912
5. Cimprich B., Reuter-Lorenz P., Nelson J., Clark P.M., Therrien B., Normolle D., Berman M.G., Hayes D.F., Noll D.C., Peltier S., and Welsh R.C. Prechemotherapy alterations in brain function in women with breast cancer J. Clin. Exp. Neuropsychol. 32 3 2010 324 331 10.1080/13803390903032537 19642048
6. Crawford J.R., Garthwaite P.H., Longman R.S., and Batty A.M. Some supplementary methods for the analysis of WAIS-IV index scores in neuropsychological assessment J. Neuropsychol. 6 2 2012 192 211 10.1111/j.1748-6653.2011.02022.x 22257377
7. Crawford J.R., Garthwaite P.H., Morrice N., and Duff K. Some supplementary methods for the analysis of the RBANS Psychol. Assess. 24 2012 365 374 10.1037/a0025652 21942233
8. Crawford J.R., Garthwaite P.H., Sutherland D., and Borland N. Some supplementary methods for the analysis of the Delis-Kaplan Executive Function System Psychol. Assess. 23 2011 888 898 10.1037/a0023712 21574720
9. Daselaar S.M., Iyengar V., Davis S.W., Eklund K., Hayes S.M., and Cabeza R.E. Less wiring, more firing: low-performing older adults compensate for impaired white matter with greater neural activity Cereb. Cortex 2013 10.1093/cercor/bht289 24152545
10. DeCarlo L.T. On the meaning and use of kurtosis Psychol. Methods 2 3 1997 292 307 10.1037/1082-989X.2.3.292
11. Deprez S., Amant F., Smeets A., Peeters R., Leemans A., Van Hecke W., Verhoeven J.S., Christiaens M.R., Vandenberghe J., Vandenbulcke M., and Sunaert S. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning J. Clin. Oncol. 30 3 2012 274 281 10.1200/JCO.2011.36.8571 22184379
12. De Ruiter M.B., L. Reneman, W. Boogerd, D.J. Veltman, M. Caan, G. Douaud, C. Lavini, S.C. Linn, E. Boven, F.S.A.M. van Dam, and S.B. Schagen Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging Human Brain Mapping. 33 12 2011 2971 2983 10.1002/hbm.21422
13. Fazekas F., J.B. Chawluk, A. Alavi, H.I. Hurtig, and R.A. Zimmerman MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging Am. J. Roentgenol. 149 2 1987 351 356 10.2214/ajr.149.2.351
14. Hedayati E., Schedin A., Nyman H., Alinaghizadeh H., and Albertsson M. The effects of breast cancer diagnosis and surgery on cognitive functions Acta Oncol. Stockh., Sweden 50 2011 1027 1036 10.3109/0284186X.2011.572911 21554027
15. Hofman M., Ryan J.L., Figueroa-Moseley C.D., Jean-Pierre P., and Morrow G.R. Cancer-related fatigue: the scale of the problem Oncologist 12 Suppl. 1 2007 4 10 10.1634/theoncologist.12-S1-4 17573451
16. Jager G., Van Hell H.H., De Win M.M., Kahn R.S., Van Den Brink W., Van Ree J.M., and Ramsey N.F. Effects of frequent cannabis use on hippocampal activity during an associative memory task Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 17 4 2007 289 297 10.1016/j.euroneuro.2006.10.003 17137758
17. Kirschbaum C., Tietze A., Skoluda N., and Dettenborn L. Hair as a retrospective calendar of cortisol production-increased cortisol incorporation into hair in the third trimester of pregnancy Psychoneuroendocrinology 34 1 2009 32 37 10.1016/j.psyneuen.2008.08.024 18947933
18. Koppelmans V., Breteler M.M., Boogerd W., Seynaeve C., Gundy C., and Schagen S.B. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy J. Clin. Oncol. 30 10 2012 1080 1086 10.1200/JCO.2011.37.0189 22370315
19. Lange M., Giffard B., Noal S., Rigal O., Kurtz J.-E., Heutte N., Lévy C., Allouache D., Rieux C., Le Fel J., Daireaux A., Clarisse B., Veyret C., Barthélémy P., Longato N., Eustache F., and Joly F. Baseline cognitive functions among elderly patients with localised breast cancer Eur. J. Cancer 50 2014 2181 2189 10.1016/j.ejca.2014.05.026 24958735
20. López Zunini R.A., Scherling C., Wallis N., Collins B., Mackenzie J., Bielajew C., and Smith A.M. Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study Brain Imaging Behav. 7 4 2013 460 477 10.1007/s11682-012-9213-0 23242968
21. Mandelblatt J.S., Stern R.A., Luta G., McGuckin M., Clapp J.D., Hurria A., Jacobsen P.B., Faul L.A., Isaacs C., Denduluri N., Gavett B., Traina T.A., Johnson P., Silliman R.A., Turner R.S., Howard D., Van Meter J.W., Saykin A., and Ahles T. Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? J. Clin. Oncol. 32 18 2014 1909 1918 10.1200/JCO.2013.54.2050
22. Marcotte T.D., Scott J.C., Kamat J., and Heaton R.K. Neuropsychology and the prediction of everyday functioning T.D. Marcotte, I. Grant, Neuropsychology of Everyday Functioning 2010 Guilford Press New York 5 38
23. Mazaika P., Hoeft F., Glover G., and Reiss A. Methods and software for fMRI analysis for clinical subjects The Organization of Human Brain Mapping, 15th Annual Meeting; 2009 Jun 18-23; 2009; San Francisco, CA 2009 The Organization of Human Brain Mapping Minneapolis, MN.
24. McDonald B.C., Conroy S.K., Ahles T.A., West J.D., and Saykin A.J. Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study J. Clin. Oncol. 30 20 2012 2500 2508 10.1200/JCO.2011.38.5674 22665542
25. McDonald B.C., and Saykin A.J. Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations Brain Imaging Behav. 7 4 2013 374 387 10.1007/s11682-013-9256-x 23996156
26. Nichols T.E., and Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples Human Brain Mapping 15 1 2002 1 25 10.1002/hbm.1058 11747097
27. Ocon A.J. Caught in the thickness of brain fog: exploring the cognitive symptoms of chronic fatigue syndrome Front. Physiol. 4 2013 63 10.3389/fphys.2013.00063 23576989
28. Pomykala K.L., de Ruiter M.B., Deprez S., McDonald B.C., and Silverman D.H. Integrating imaging findings in evaluating the post-chemotherapy brain Brain Imaging Behav. 7 4 2013 436 452 10.1007/s11682-013-9239-y 23828813
29. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra Magn. Reson. Med. 30 6 1993 672 679 10.1002/mrm.1910300604 8139448
30. Schagen S.B., Muller M.J., Boogerd W., Mellenbergh G.J., and van Dam F.S. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients J. Natl. Cancer Inst. 98 23 2006 1742 1745 10.1093/jnci/djj470 17148777
31. Scherling C., Collins B., Mackenzie J., Bielajew C., and Smith A. Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study Front. Hum. Neurosci. 5 November 2011 122 10.3389/fnhum.2011.00122 22053153
32. Scherling C., Collins B., Mackenzie J., Bielajew C., and Smith A. Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: a functional magnetic resonance imaging study J. Clin. Exp. Neuropsychol. 37-41 5 2012 543 560 10.1080/13803395.2012.666227 22380580
33. Schmand B., Lindeboom J., Harskamp F., and van De Nederlandse Leestest voor Volwassenen 1992 Swets & Zeitlinger Lisse
34. Seigers R., Schagen S.B., Van Tellingen O., and Dietrich J. Chemotherapy-related cognitive dysfunction: current animal studies and future directions Brain Imaging Behav. 7 4 2013 453 459 10.1007/s11682-013-9250-3 23949877
35. Smith S.M., Jenkinson M., Johansen-Berg H., Rueckert D., Nichols T.E., Mackay C.E., Watkins K.E., Ciccarelli O., Cader M.Z., Matthews P.M., and Behrens T.E. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data NeuroImage 31 4 2006 1487 1505 10.1016/j.neuroimage.2006.02.024 16624579
36. Van den Heuvel O.A., Groenewegen H.J., Barkhof F., Lazeron R.H., van Dyck R., and Veltman D.J. Frontostriatal system in planning complexity: a parametric functional magnetic resonance version of Tower of London task NeuroImage 18 2 2003 367 374 10.1016/S1053-8119(02)00010-1 12595190
37. Vardy J., Dhillon H.M., Pond G.R., Rourke S.B., Xu W., Dodd A., Renton C., Park A., Bekele T., Ringash J., Zhang H., Burkes R., Clarke S.J., and Tannock I.F. Cognitive function and fatigue after diagnosis of colorectal cancer Ann. Oncol. 25 12 2014 2404 2412 10.1093/annonc/mdu448 25214544
38. Wefel J.S., Lenzi R., Theriault R., Buzdar A.U., Cruickshank S., and Meyers C.A. "Chemobrain" in breast carcinoma?: a prologue Cancer 101 3 2004 466 475 10.1002/cncr.20393 15274059
39. Wefel J.S., and Schagen S.B. Chemotherapy-related cognitive dysfunction Curr. Neurol. Neurosci. Rep. 12 3 2012 267 275 10.1007/s11910-012-0264-9 22453825
40. Wefel J.S., Vardy J., Ahles T., and Schagen S.B. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer Lancet Oncol. 12 7 2011 703 708 10.1016/S1470-2045(10)70294-1 21354373